Search Results - Anne Ma Dyrhol-Riise
- Showing 1 - 14 results of 14
-
1
-
2
Whole blood RNA signatures in tuberculosis patients receiving H56:IC31 vaccine as adjunctive therapy by Noelia Alonso-Rodríguez, Eleonora Vianello, Suzanne van Veen, Synne Jenum, Kristian Tonby, Kristian Tonby, Rosalie van Riessen, Xiaoran Lai, Rasmus Mortensen, Tom H. M. Ottenhoff, Anne Ma Dyrhol-Riise, Anne Ma Dyrhol-Riise
Published in Frontiers in Immunology (2024-02-01)Get full text
Article -
3
-
4
Plasma LOX-Products and Monocyte Signaling Is Reduced by Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients by Marthe Jøntvedt Jørgensen, Marthe Jøntvedt Jørgensen, Kristin G. Nore, Hans Christian D. Aass, Emilie Layre, Jérôme Nigou, Rasmus Mortensen, Kjetil Tasken, Kjetil Tasken, Dag Kvale, Synne Jenum, Kristian Tonby, Kristian Tonby, Anne Ma Dyrhol-Riise, Anne Ma Dyrhol-Riise
Published in Frontiers in Cellular and Infection Microbiology (2021-07-01)Get full text
Article -
5
Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial. by Christian Prebensen, Marius Trøseid, Thor Ueland, Anders Dahm, Per Morten Sandset, Ingeborg Aaberge, Kristian Waalen, Anne Ma Dyrhol-Riise, Kjetil Taskén, Dag Kvale
Published in PLoS ONE (2017-01-01)Get full text
Article -
6
Author Correction: Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice by Rasmus Mortensen, Helena Strand Clemmensen, Joshua S. Woodworth, Marie Louise Therkelsen, Tehmina Mustafa, Kristian Tonby, Synne Jenum, Else Marie Agger, Anne Ma Dyrhol-Riise, Peter Andersen
Published in Communications Biology (2024-05-01)Get full text
Article -
7
The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis by Thale D. J. Hovdun Patrick-Brown, Andreas Barratt-Due, Marius Trøseid, Anne Ma Dyrhol-Riise, Katerina Nezvalova-Henriksen, Trine Kåsine, Pål Aukrust, Inge C. Olsen, NOR Solidarity consortium
Published in Communications Medicine (2024-11-01)Get full text
Article -
8
High neopterin and IP-10 levels in cerebrospinal fluid are associated with neurotoxic tryptophan metabolites in acute central nervous system infections by Else Quist-Paulsen, Pål Aukrust, Anne-Marte Bakken Kran, Oona Dunlop, Vidar Ormaasen, Birgitte Stiksrud, Øivind Midttun, Thor Ueland, Per Magne Ueland, Tom Eirik Mollnes, Anne Ma Dyrhol-Riise
Published in Journal of Neuroinflammation (2018-11-01)Get full text
Article -
9
Vaccine responses and hybrid immunity in people living with HIV after SARS-CoV-2 breakthrough infections by Amin Alirezaylavasani, Linda Gail Skeie, Ingrid Marie Egner, Adity Chopra, Tuva Børresdatter Dahl, Christian Prebensen, John Torgils Vaage, Bente Halvorsen, Fridtjof Lund-Johansen, Kristian Tonby, Dag Henrik Reikvam, Birgitte Stiksrud, Jan Cato Holter, Anne Ma Dyrhol-Riise, Ludvig A. Munthe, Hassen Kared
Published in npj Vaccines (2024-10-01)Get full text
Article -
10
Anti-PF4/polyanion antibodies in COVID-19 patients are associated with disease severity and pulmonary pathology by Thor Ueland, Ingvild Hausberg, Trude Victoria Mørtberg, Tuva Børresdatter Dahl, Tøri Vigeland Lerum, Annika Michelsen, Trine Ranheim, Katerina Nezvalova Henriksen, Anne Ma Dyrhol-Riise, Pål André Holme, Trond Mogens Aaløkken, Ole Henning Skjønsberg, Andreas Barratt-Due, Maria Therese Ahlén, Pål Aukrust, Bente Halvorsen
Published in Platelets (2022-05-01)Get full text
Article -
11
Extracellular matrix remodelling pathway in peripheral blood mononuclear cells from severe COVID-19 patients: an explorative study by Sarah Louise Murphy, Sarah Louise Murphy, Nora Reka Balzer, Nora Reka Balzer, Nora Reka Balzer, Trine Ranheim, Ellen Lund Sagen, Ellen Lund Sagen, Camilla Huse, Camilla Huse, Camilla Huse, Vigdis Bjerkeli, Vigdis Bjerkeli, Annika E. Michelsen, Annika E. Michelsen, Ane-Kristine Finbråten, Lars Heggelund, Lars Heggelund, Anne Ma Dyrhol-Riise, Anne Ma Dyrhol-Riise, Anders Tveita, Anders Tveita, Aleksander Rygh Holten, Aleksander Rygh Holten, Marius Trøseid, Marius Trøseid, Marius Trøseid, Thor Ueland, Thor Ueland, Thor Ueland, Thomas Ulas, Thomas Ulas, Thomas Ulas, Pål Aukrust, Pål Aukrust, Pål Aukrust, Andreas Barratt-Due, Andreas Barratt-Due, Bente Halvorsen, Bente Halvorsen, Bente Halvorsen, Tuva Børresdatter Dahl
Published in Frontiers in Immunology (2024-06-01)Get full text
Article -
12
Gut microbiota composition during hospitalization is associated with 60-day mortality after severe COVID-19 by Marius Trøseid, Jan Cato Holter, Kristian Holm, Beate Vestad, Taisiia Sazonova, Beathe K. Granerud, Anne Ma Dyrhol-Riise, Aleksander R. Holten, Kristian Tonby, Anders Benjamin Kildal, Lars Heggelund, Anders Tveita, Simen Bøe, Karl Erik Müller, Synne Jenum, Johannes R. Hov, Thor Ueland, Norwegian SARS-CoV-2 study group
Published in Critical Care (2023-02-01)Get full text
Article -
13
Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet studyResearch in context by Martina Sester, Neus Altet-Gomez, Åse Bengaard Andersen, Miguel Arias-Guillén, Korkut Avsar, Anne-Marte Bakken Kran, Graham Bothamley, Anne Christine Nordholm Breschel, James Brown, Dumitru Chesov, Nelly Ciobanu, Daniela Maria Cirillo, Valeriu Crudu, Malu de Souza Galvao, Asli Görek Dilektasli, José Dominguez, Raquel Duarte, Anne Ma Dyrhol-Riise, Delia Goletti, Harald Hoffmann, Elmira Ibraim, Barbara Kalsdorf, Marcin Krawczyk, Heinke Kunst, Berit Lange, Marc Lipman, Alberto Matteelli, Piotr Milkiewicz, David Neyer, Martin Nitschke, Haluk Barbaros Oral, Juan José Palacios-Gutiérrez, Elisa Petruccioli, Joanna Raszeja-Wyszomirska, Pernille Ravn, Jan Rupp, Hanna-Elisa Spohn, Corina Toader, Raquel Villar-Hernandez, Dirk Wagner, Frank van Leth, Leonardo Martinez, Ole Skouvig Pedersen, Christoph Lange
Published in The Lancet Regional Health. Europe (2025-10-01)Get full text
Article -
14
Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trialResearch in context by Hans-Kittil Viermyr, Kristian Tonby, Erica Ponzi, Sophie Trouillet-Assant, Julien Poissy, José R. Arribas, Virginie Dyon-Tafani, Maude Bouscambert-Duchamp, Lambert Assoumou, Bente Halvorsen, Nuriye Basdag Tekin, Alpha Diallo, Lucie De Gastines, Ludvig A. Munthe, Sarah Louise Murphy, Thor Ueland, Annika E. Michelsen, Fridtjof Lund-Johansen, Pål Aukrust, Joy Mootien, Benjamin Dervieux, Yoann Zerbib, Jean-Christophe Richard, Renaud Prével, Denis Malvy, Jean-François Timsit, Nathan Peiffer-Smadja, Damien Roux, Lionel Piroth, Hafid Ait-Oufella, Cesar Vieira, Olav Dalgard, Lars Heggelund, Karl Erik Müller, Jannicke Horjen Møller, Anders Benjamin Kildal, Vegard Skogen, Saad Aballi, Jonas Daniel Sjøberg Øgaard, Anne Ma Dyrhol-Riise, Anders Tveita, Amin Alirezaylavasani, Dominique Costagliola, Yazdan Yazdanpanah, Inge Christoffer Olsen, Tuva Børresdatter Dahl, Hassen Kared, Aleksander Rygh Holten, Marius Trøseid
Published in EBioMedicine (2025-01-01)Get full text
Article
